Condition
Glioblastoma WHO Grade IV clinical trials and research
Research outlook What's coming for Glioblastoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Glioblastoma WHO Grade IV clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Early Phase 1 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Testing BMS-986504 in patients with recurrent glioblastoma
This study is testing a new drug called BMS-986504 in patients with recurrent glioblastoma who have a specific genetic change to see if it is safe and how well it works before surgery.
-
BC008-1A injections for recurrent WHO grade 4 glioma
This trial tests whether BC008-1A, a bispecific antibody that targets PD‑1 and TIGIT, is safe and shows early anti-tumor activity in adults with recurrent WHO grade 4 glioma.
Related topics
Quick answers
How many Glioblastoma WHO Grade IV clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.